日本臨床薬理学会学術総会抄録集
Online ISSN : 2436-5580
第44回日本臨床薬理学会学術総会
セッションID: 44_2-C-SL
会議情報

特別講演
Model Informed Drug Discovery, Development, and Utilization in theAge of Artificial Intelligence and Machine Learning
*Cynthia J. (C.J.) Musante
著者情報
会議録・要旨集 フリー

詳細
抄録

In this talk, I will introduce model informed drug discovery, development, andutilization (MIDD), including recent examples, and will discuss the challengesand opportunities that the new era of artificial intelligence and machinelearning (AI/ML) offers to clinical pharmacology and therapeutics. I also willprovide an introduction to the International Society of Pharmacometrics (ISoP)and its role in advancing the science and impact of MIDD. As part of the lattertopic, I will discuss highlights from the two recent joint FDA-ISoP Workshops onquantitative methods in dosage optimization of oncology products.

著者関連情報
© 2023 日本臨床薬理学会
前の記事 次の記事
feedback
Top